Fig. 7From: Combined with UPLC-Triple-TOF/MS-based plasma lipidomics and molecular pharmacology reveals the mechanisms of schisandrin against Alzheimer’s diseaseA The possible active site is shown in white and red spheres; B the receptor goes into the active pocket; C the receptor form of the optimal conformation; D two-dimensional interaction map of schisandrin and inward-facing structure of LXRβBack to article page